Gianna Zuccotti, MD

Gianna Zuccotti, MD Associate Chairman for Clinical Affairs, Department ofMedicine Memorial Sloan-Kettering Cancer Center

Phone
212-639-3119

Education
MD, Mount Sinai School of Medicine; MPH, Columbia University School of Public Health

Residencies
New York Presbyterian Hospital-Weill Medical College of Cornell University

Fellowship
Montefiore Medical Center - Albert Einstein College of Medicine

Board Certification
Internal Medicine; Infectious Diseases

Academic Appointments
Weill Medical College of Cornell University

Hospital Appointments
Memorial Hospital for Cancer and Allied Diseases; NewYork Presbytarian Hospital; Hospital for Special Surgery

Research Interests

Dr. Zuccotti joined the MSKCC faculty full-time in 2001 after spending two years in the Infectious Disease Division of New York Presbyterian Hospital. Her clinical interests focus on housestaff and fellow education and she is the Program Director of the Internal Medicine Residency Program. She sees both inpatient and outpatient general infectious disease consultations and has a special interest in travel health. She has held the position of Clinical Director at the International Health Care Service at Weill Medical College of Cornell University and continues to see pre- and post-travel consultations on a weekly basis.

Dr. Zuccotti's research interests relate to hospital epidemiology, infection control and antibiotic utilization. Using the techniques of pulsed-field gel electrophoresis (PFGE), plasmid profiling and PCR she has studied the molecular epidemiology of nosocomial Acinetobacter anitratus infection. In addition, she has supervised the evaluation of a pseudo-outbreak of multi-drug resistant Mycobacterium tuberculosis and investigated the risk factors for infection with other drug-resistant organisms, in particular Klebsiella pneumoniae. More recently, she is participating in ongoing projects using PFGE to monitor nosocomial transmission of VRE and MRSA.

In conjunction with the Pharmacy Division at New York Presbyterian Hospital, she was instrumental in the development of an antibacterial restriction program that used both Infectious Disease fellows and hospital pharmacists to standardize antibacterial utilization. Her research related to antibiotic control has included projects investigating the pharmacoeconomics of antibacterial utilization and the effects on microbial resistance, pathogen prevalence and health care cost. She was a co-investigator on a two-year project examining the economic consequences of antibacterial resistance in community-acquired pneumonia and has served as the infectious disease consultant for a project funded by the Agency for Healthcare Research and Quality (AHRQ) evaluating integrated delivery systems and clinical preparedness for bioterrorist events.

In addition to her activities in the Division, Dr. Zuccotti is the Deputy Editor at The Medical Letter. As Deputy Editor, she interacts with experts from all fields of medicine at institutions around the globe. She writes reviews and edits articles for the publication on Infectious Diseases and many other branches of medicine. She is also a Contributing Editor at the Journal of The American Medical Association, where she coordinates reviews and publication of Infectious Disease submissions.

Recent Publications:

1. Warren DK, Cosgrove SE, Deikema DJ, Zuccotti G, Climo MW, Bolon MK, Tokars JI, Noskin GA, Wong ES, Sepkowitz KA, Herwaldt LA, Perl TM, Solomon SL, Fraser VJ, for the Prevention Epicenter Group. A Multicenter Intervention to Prevent Catheter-Associated Bloodstream Infections. Infect Control Hosp Epidemiol 2006; 27:662.[PubMed Abstract]
2. Kamboj M, Zuccotti G. Infections in returning travelers. Infection in Medicine 2006; 23: 56.
3. Weinstock D, Zuccotti G. Adamantane resistance in influenza A. JAMA 2006; 295(8):934.[PubMed Abstract]
4. Zuccotti G. Generation Rx: how prescription drugs are altering American lives, minds and bodies (book review). J Clin Invest 2006; 116:287.
5. Warren DK, Yokoe DS, Climo MW, Herwaldt LA, Noskin GA, Zuccotti G, Tokars JI, Perl TM, Fraser VJ. Preventing catheter-associated bloodstream infections: a survey of policies for the insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol, 2006; 27(1): 8.[PubMed Abstract]
6. Zuccotti G, Strasfeld L, Weinstock DM. New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients. Expert Opin Pharmacother 2005; 6: 1669. [PubMed Abstract]
7. Yokoe DS, Noskin GA, Cunningham SM, Zuccotti G, Plaskett T, Fraser VJ, Olsen MA, Tokars JI, Solomon S, Perl TM, Cosgrove SE, Tilson RS, Greenbaum M, Hooper DC, Sands KE, Tully J, Herwaldt LA, Diekema DJ, Wong ES, Climo M, Platt R. Enhanced identification of postoperative infections. Emerg Infect Dis 2004; 10:1924[PubMed Abstract]
8. Sohn S, Eagan J, Sepkowitz KA, Zuccotti G. Effect of implementing safety-engineered devices on percutaneous injury epidemiology. Infect Control Hosp Epidemiol. 2004; 25(7): 536-42. [PubMed Abstract]
9. Zuccotti G, Sepkowitz KS. Infection Control in Oncology Patients. In: Management of Infection in Oncology Patients. JR Wingard, R Bowdin (Eds.) Martin Dunitz, London. 2003.
10. Weinstock DM, Gubareva IV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med. 2003; 348(9): 867-8. [PubMed Abstract]
11. Bearman G, Vaamonde C, Larone D, Drusin L, Zuccotti G. Pseudo-outbreak of multidrug-resistant Mycobacterium tuberculosis associate with presumed laboratory processing contamination. Infect Control Hosp Epidemiol. 2002; 23(10): 620-2. [PubMed Abstract]